Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Thermo Fisher, NX Prenatal Partner on Pregnancy Outcome Assay Development

Thermo Fisher, NX Prenatal Partner on Pregnancy Outcome Assay Development

Apr 16, 2019
|
staff reporter

NEW YORK (GenomeWeb) — Thermo Fisher Scientific and NX Prenatal said today that they have partnered on the development of mass spectrometry-based proteomics assays for adverse pregnancy outcomes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
18
Featured Webinar

COVID-19 Wastewater-Based Epidemiology: Methods and Insights for SARS-CoV-2 Community Surveillance

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Molecular Diagnostics

  1. Laboratory, Provider Organizations Urge HHS to Update COVID-19 Testing Prioritization Guidelines

  2. Sherlock Bio, Dartmouth-Hitchcock Health Partner on Clinical Study of Sherlock CRISPR SARS-CoV-2 Kit

  3. Solaris Diagnostics, Alpha Genomix Coronavirus Tests Get FDA Emergency Use Authorization

  4. HTG Molecular Q2 Revenues Drop 66 Percent as COVID-19 Forces Global Facility Closures

  5. T2 Biosystems Q2 Revenues Up 41 Percent, Beat Estimates

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.